Use of inhibitors of vacuolar-type h atpases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/415 (2006.01) A61K 31/16 (2006.01) A61K 31/71 (1995.01)

Patent

CA 2142313

The activity of inhibitors of vacuolar type H + -ATPases in the inhibition of vacuolation induced by Helicobacter pylori is disclosed. Preferred agents are the macrolide antibiotics bafilomycins A1, A2, B1, B2, C1, C2 and D, especially bafilomycin A1. The use of such compounds in the treatment of diseases, including peptic ulceration, is claimed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of inhibitors of vacuolar-type h atpases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of inhibitors of vacuolar-type h atpases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of vacuolar-type h atpases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1433246

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.